Menlo Therapeutics Inc (MNLO) Stock News

NASDAQ:MNLO - Nasdaq -

1.35 -0.03 (-2.17%)

After market: 1.38 +0.03 (+2.22%)

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

MNLO Latest News, Press Relases and Analysis

All

Press Releases

5 years ago - By: Seeking Alpha

Menlo Therapeutics changes name to Vyne Therapeutics (NASDAQ:MNLO)

5 years ago - By: Analyst Ratings

News Image

LifeSci Capital Sticks to Its Buy Rating for Menlo Therapeutics (MNLO)

5 years ago - By: Analyst Ratings - Mentions: INMB

News Image

Analysts Offer Insights on Healthcare Companies: Menlo Therapeutics (NASDAQ: MNLO) and Inmune Bio (NASDAQ: INMB)

5 years ago - By: Analyst Ratings

News Image

Menlo Therapeutics (MNLO) Received its Third Buy in a Row

5 years ago - By: Zacks Investment Research

Menlo Therapeutics Inc. (MNLO) Reports Q2 Loss, Tops Revenue Estimates

5 years ago - By: Seeking Alpha - Mentions: MVIS OSUR FSLY APRN ...

FSLY, WDC among premarket losers

5 years ago - By: Benzinga - Mentions: GSX GV TGB AVCT ...

110 Biggest Movers From Yesterday

5 years ago - By: Seeking Alpha

Menlo Therapeutics EPS misses by $0.93, beats on revenue (NASDAQ:MNLO)

5 years ago - By: Benzinga

News Image

Why Menlo Therapeutics Is Trading Lower Today

5 years ago - By: Smarter Analyst

Menlo Therapeutics (MNLO) Received its Third Buy in a Row

5 years ago - By: The Motley Fool

Why Menlo Therapeutics Stock Sank Today

5 years ago - By: Seeking Alpha - Mentions: SIEN TTPH IMUX CJJD ...

Healthcare - Top 5 Gainers / Losers

5 years ago - By: Seeking Alpha

Menlo Therapeutics drops 17% after pricing equity offering (NASDAQ:MNLO)

5 years ago - By: Seeking Alpha

Menlo Therapeutics readies equity offering (NASDAQ:MNLO)

5 years ago - By: Seeking Alpha

Menlo combo skin foam shows positive action in mid-stage acne study (NASDAQ:MNLO)

5 years ago - By: Smarter Analyst

Menlo Therapeutics (MNLO) Received its Third Buy in a Row